Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Zhaohui Ye
Affiliation
Center for Biologics Evaluation and Research
ORCID
Career Start Year
2002
Papers
71
H Index
38
Expertise
CM4AI Collaborator
Prashant Mali (CM4AI)
PMID
Paper Title
Journal Title
Published Year
37156062
Generation of induced pluripotent stem cell lines from helper and cytotoxic T cells of healthy individuals.
Stem Cell Res
2023
33467883
Convergence of human pluripotent stem cell, organoid, and genome editing technologies.
Exp Biol Med (Maywood)
2021
33408528
Study on Targeting Relationship Between miR-320b and FGD5-AS1 and Its Effect on Biological Function of Osteosarcoma Cells.
Cancer Manag Res
2020
32101839
MiR-140-3p Ameliorates the Progression of Osteoarthritis via Targeting CXCR4.
Biol Pharm Bull
2020
30471152
Transient c-Src Suppression During Endodermal Commitment of Human Induced Pluripotent Stem Cells Results in Abnormal Profibrotic Cholangiocyte-Like Cells.
Stem Cells
2019
31767844
Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing.
Nat Commun
2019
30803263
Human-relevant preclinical in vitro models for studying hepatobiliary development and liver diseases using induced pluripotent stem cells.
Exp Biol Med (Maywood)
2019
30358741
Biliary Atresia Relevant Human Induced Pluripotent Stem Cells Recapitulate Key Disease Features in a Dish.
J Pediatr Gastroenterol Nutr
2019
29164808
A Universal Approach to Correct Various HBB Gene Mutations in Human Stem Cells for Gene Therapy of Beta-Thalassemia and Sickle Cell Disease.
Stem Cells Transl Med
2018
29034890
Derivation of a disease-specific human induced pluripotent stem cell line from a biliary atresia patient.
Stem Cell Res
2017
28395806
Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
Stem Cell Res
2017
28441409
A hypomorphic PIGA gene mutation causes severe defects in neuron development and susceptibility to complement-mediated toxicity in a human iPSC model.
PLoS One
2017
26896603
Genome editing systems in novel therapies.
Discov Med
2016
27138846
Efficient and Controlled Generation of 2D and 3D Bile Duct Tissue from Human Pluripotent Stem Cell-Derived Spheroids.
Stem Cell Rev Rep
2016
27256364
Gene correction in patient-specific iPSCs for therapy development and disease modeling.
Hum Genet
2016
27037079
Genome Editing in Human Pluripotent Stem Cells.
Cold Spring Harb Protoc
2016
27037073
A Method for Genome Editing in Human Pluripotent Stem Cells.
Cold Spring Harb Protoc
2016
25504624
Covalent modification of a cysteine residue in the XPB subunit of the general transcription factor TFIIH through single epoxide cleavage of the transcription inhibitor triptolide.
Angew Chem Int Ed Engl
2015
25862562
Modified Ham test for atypical hemolytic uremic syndrome.
Blood
2015
25702619
Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.
Stem Cells
2015
25742692
A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.
Stem Cells Transl Med
2015
25418680
Efficient and allele-specific genome editing of disease loci in human iPSCs.
Mol Ther
2015
23066813
Roles of reactive oxygen species in the fate of stem cells.
Antioxid Redox Signal
2014
25473036
Effectiveness of exome and genome sequencing guided by acuity of illness for diagnosis of neurodevelopmental disorders.
Sci Transl Med
2014
24996165
Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs.
Cell Stem Cell
2014
24357517
Early frameshift mutation in PIGA identified in a large XLID family without neonatal lethality.
Hum Mutat
2014
24105986
Differential sensitivity to JAK inhibitory drugs by isogenic human erythroblasts and hematopoietic progenitors generated from patient-specific induced pluripotent stem cells.
Stem Cells
2014
24002691
Extensive ex vivo expansion of functional human erythroid precursors established from umbilical cord blood cells by defined factors.
Mol Ther
2014
23372166
RUNX1a enhances hematopoietic lineage commitment from human embryonic stem cells and inducible pluripotent stem cells.
Blood
2013
24113066
Generation of glycosylphosphatidylinositol anchor protein-deficient blood cells from human induced pluripotent stem cells.
Stem Cells Transl Med
2013
23813938
Response: the role of RUNX1 isoforms in hematopoietic commitment of human pluripotent stem cells.
Blood
2013
23812546
Generation and homing of iPSC-derived hematopoietic cells in vivo.
Mol Ther
2013
23325555
Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells.
Hepatology
2013
22385660
Low incidence of DNA sequence variation in human induced pluripotent stem cells generated by nonintegrating plasmid expression.
Cell Stem Cell
2012
23080273
Generation of integration-free human induced pluripotent stem cells from postnatal blood mononuclear cells by plasmid vector expression.
Nat Protoc
2012
22619021
Promise and challenges of human iPSC-based hematologic disease modeling and treatment.
Int J Hematol
2012
22225458
Efficient derivation and genetic modifications of human pluripotent stem cells on engineered human feeder cell lines.
Stem Cells Dev
2012
22305531
The phenotype of a germline mutation in PIGA: the gene somatically mutated in paroxysmal nocturnal hemoglobinuria.
Am J Hum Genet
2012
21243013
Efficient human iPS cell derivation by a non-integrating plasmid from blood cells with unique epigenetic and gene expression signatures.
Cell Res
2011
21857158
Hematopoietic cells as sources for patient-specific iPSCs and disease modeling.
Cell Cycle
2011
21628406
Reprogramming of EBV-immortalized B-lymphocyte cell lines into induced pluripotent stem cells.
Blood
2011
21750407
Liver engraftment potential of hepatic cells derived from patient-specific induced pluripotent stem cells.
Cell Cycle
2011
21439256
Molecular imaging and stem cell research.
Mol Imaging
2011
21393480
Hematopoietic stem/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood.
Blood
2011
20336524
An improved method for generating and identifying human induced pluripotent stem cells.
Methods Mol Biol
2010
20632856
Potential of human induced pluripotent stem cells derived from blood and other postnatal cell types.
Regen Med
2010
20201064
Butyrate greatly enhances derivation of human induced pluripotent stem cells by promoting epigenetic remodeling and the expression of pluripotency-associated genes.
Stem Cells
2010
20432258
Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes.
Hepatology
2010
18563409
In vivo functional efficacy of tumor-specific T cells expanded using HLA-Ig based artificial antigen presenting cells (aAPC).
Cancer Immunol Immunother
2009
19797525
Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.
Blood
2009
1 - 50 of 71
Column Actions
Search
Recommended Authors
Celine J Rocca
Integrare Research Unit UMR_S, Universite Paris-Saclay, University Evry, Inserm
Career Start Year
2010
Number of shared co-authors
1
Alejandro De Los Angeles
Massachusetts Institute of Technology
Career Start Year
2008
Number of shared co-authors
5
Mohammad A Mandegar
Gladstone Institute of Cardiovascular Disease
Career Start Year
2006
Number of shared co-authors
0
Yuichiro Miyaoka
Tokyo Metropolitan Institute of Medical Science, Japan Gladstone Institutes
Career Start Year
2006
Number of shared co-authors
0
Johannes Winkler
Medical University of Vienna
Career Start Year
2005
Number of shared co-authors
0
Vittorio Sebastiano
Stanford University
Career Start Year
2004
Number of shared co-authors
3
Nuria Montserrat
Catalan Institution for Research and Advanced Studies (ICREA)
Career Start Year
2004
Number of shared co-authors
2
Michael Xavier Doss
BioMarin Pharmaceutical Inc.
Career Start Year
2003
Number of shared co-authors
0
Haoyi Wang
Chinese Academy of Sciences
Career Start Year
2003
Number of shared co-authors
3
Sergei Doulatov
University of Washington
Career Start Year
2002
Number of shared co-authors
1
Guokai Chen
University of Macau
Career Start Year
2002
Number of shared co-authors
3
Thomas P Zwaka
Icahn School of Medicine at Mount Sinai
Career Start Year
2000
Number of shared co-authors
0
Amander T Clark
Center for Reproductive Science, University of California los angeles
Career Start Year
1999
Number of shared co-authors
2
Xianmin Zeng
College of Food Science and Technology, Nanjing Agricultural University
Career Start Year
1999
Number of shared co-authors
2
Yaowalak U-Pratya
Faculty of Medicine Siriraj Hospital, Mahidol University
Career Start Year
1998
Number of shared co-authors
0
Elias T Zambidis
Institute for Cell Engineering, The Johns Hopkins University School of Medicine
Career Start Year
1996
Number of shared co-authors
11
Jeanette Beers
and Blood Institute, National Institutes of Health
Career Start Year
1996
Number of shared co-authors
2
Dmitry A Ovchinnikov
The Florey Institute for Neuroscience and Mental Health, University of Melbourne
Career Start Year
1994
Number of shared co-authors
0
Yukio Nakamura
RIKEN BioResource Research Center
Career Start Year
1992
Number of shared co-authors
1
Mahendra S Rao
Institute of Stem Cells and Regenerative Medicine (inStem)
Career Start Year
1990
Number of shared co-authors
8
Christof von Kalle
Berlin Institute of Health at Charite-Universitatsmedizin Berlin
Career Start Year
1990
Number of shared co-authors
3
Juan Carlos Izpisua Belmonte
Inc., Salk Institute for Biological Studies
Career Start Year
1989
Number of shared co-authors
2
William L Stanford
Ottawa Hospital Research Institute
Career Start Year
1989
Number of shared co-authors
2
Melissa K Carpenter
Carpenter Group Consulting Inc., USA NxCell Inc., USA Q Therapeutics Inc.
Career Start Year
1988
Number of shared co-authors
1
Ernst J Wolvetang
Australian Institute for Bioengineering and Nanotechnology, University of Queensland
Career Start Year
1987
Number of shared co-authors
1
Eric E Bouhassira
Albert Einstein College of Medicine
Career Start Year
1987
Number of shared co-authors
0
Lesley M Forrester
Institute of Regeneration and Repair, The University of Edinburgh
Career Start Year
1984
Number of shared co-authors
0
Christine L Mummery
Leiden University Medical Center
Career Start Year
1981
Number of shared co-authors
2
Hiromitsu Nakauchi
Advanced Research Institute, Tokyo Medical and Dental University
Career Start Year
1981
Number of shared co-authors
3
Luigi Naldini
Vita-Salute San Raffaele University
Career Start Year
1980
Number of shared co-authors
2
row(s) 1 - 30 of 30
Collaborators
Linzhao Cheng
Johns Hopkins University School of Medicine
Co-authored papers
51
Yoon-Young Jang
Daegu Catholic University Medical Center, Catholic University of Daegu
Co-authored papers
18
Robert A Brodsky
Sidney Kimmel Cancer Center, Johns Hopkins University
Co-authored papers
10
Bin-Kuan Chou
The Institute for Cell Engineering, Johns Hopkins University
Co-authored papers
10
Prashant Mali (CM4AI)
University of California San Diego
Co-authored papers
10
Sarah N Dowey
Johns Hopkins University School of Medicine, Institute for Cell Engineering
Co-authored papers
9
Xiaobing Yu
Heidelberg University
Co-authored papers
8
Guibin Chen
and Blood Institute, National Institutes of Health
Co-authored papers
7
Cory Smith
GC Therapeutics Inc.
Co-authored papers
6
Jizhong Zou
and Blood Institute, National Institutes of Health
Co-authored papers
6
Xiaosong Huang
Guangzhou University
Co-authored papers
6
Holly Hammond
Center for Pathogen Research, University of Maryland School of Medicine
Co-authored papers
5
Cyndi F Liu
The Johns Hopkins University School of Medicine
Co-authored papers
5
Alison R Moliterno
Johns Hopkins Hospital
Co-authored papers
3
Jonathan Yen
St. Jude Children's Research Hospital
Co-authored papers
3
Liuhong Cai
Chengdu Yumei Hospital
Co-authored papers
3
Jerry L Spivak
The Johns Hopkins University School of Medicine
Co-authored papers
3
Chunlin Zou
Key Laboratory of Longevity and Aging-related Diseases(Guangxi Medical University)
Co-authored papers
3
Curt I Civin
Center for Stem Cell Biology & Regenerative Medicine and.
Co-authored papers
2
Kit Man Tsang
and Blood Institute, National Institutes of Health
Co-authored papers
2
Donna M Williams
Johns Hopkins University School of Medicine
Co-authored papers
2
Betty Y Zhou
Shenzhen Alpha-biotechnology Inc. Shenzhen
Co-authored papers
2
Dong-Er Zhang
Moores Cancer Center, University of California San Diego
Co-authored papers
2
Leslie G Biesecker
National Human Genome Research Institute, National Institutes of Health
Co-authored papers
2
Linda M S Resar
Johns Hopkins University School of Medicine
Co-authored papers
2
Yu Alex Zhang
Beijing Institute for Brain Disorders
Co-authored papers
2
Nancy F Hansen
National Human Genome Research Institute, National Institutes of Health
Co-authored papers
1
Holly H Hommond
Co-authored papers
1
Stacey Thibodeau-Beganny
Amherst College
Co-authored papers
1
Tien Peng
Department of Medicine Cardiovascular Institute and Division of Pulmonary
Co-authored papers
1
1 - 30